A-17

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameA-17
Drug Alias NameAngstrom-17tumor-targeting technology (Angstrom)A-17
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasminogen activators modulators
TargetsPlasminogen activators
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSplash Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSplash Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A